Table 2 Adverse events “possibly” or... | American Society of Hematology

Table 2

Adverse events “possibly” or “probably” related to IPH2101 cohort

Event	Grade	0.075 mg/kg	1 mg/kg	3 mg/kg	Total
Constitutional
Pyrexia	1	0	0	3	3
Fatigue	1	0	0	2	2
Chills	1	0	1	2	3
Flushing	1	0	0	1	1
Headache	1	0	1	1	2
Cardiac
Tachycardia	2	1	0	0	1
Gastrointestinal
Abdominal pain	1	1	0	0	1
Nausea	1	0	1	0	1
Diarrhea	1,2	0	0	2	2
Laboratory values
Neutrophil decrease	3	0	0	1	1
Creatinine increase	4*	1*	0	0	1*
Renal/metabolism
Acute renal failure	3*	1*	0	0	1*
Hyperuricemia	4*	1*	0	0	1*
Hyperkalemia	4*	1*	0	0	1*

Event	Grade	0.075 mg/kg	1 mg/kg	3 mg/kg	Total
Constitutional
Pyrexia	1	0	0	3	3
Fatigue	1	0	0	2	2
Chills	1	0	1	2	3
Flushing	1	0	0	1	1
Headache	1	0	1	1	2
Cardiac
Tachycardia	2	1	0	0	1
Gastrointestinal
Abdominal pain	1	1	0	0	1
Nausea	1	0	1	0	1
Diarrhea	1,2	0	0	2	2
Laboratory values
Neutrophil decrease	3	0	0	1	1
Creatinine increase	4*	1*	0	0	1*
Renal/metabolism
Acute renal failure	3*	1*	0	0	1*
Hyperuricemia	4*	1*	0	0	1*
Hyperkalemia	4*	1*	0	0	1*

Adverse event occurring in the same patient on cohort 4.